Position in MGTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$487,150
+$193,000 QoQ
Shares Held
56,253
+52.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in MGTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $487,150 | 56,253 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $294,150 | 37,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $581,038 | 70,600 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $230,261 | 33,962 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $109,903 | 18,106 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $371,624 | 52,938 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $192,059 | 29,457 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $150,643 | 19,900 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $274,230 | 19,800 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $610,118 | 25,700 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||